Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Receivables: 2021-2022

Historic Receivables for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $73.8 million.

  • ADC Therapeutics' Receivables fell 15.10% to $21.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $142.9 million, marking a year-over-year increase of 81.41%. This contributed to the annual value of $73.8 million for FY2022, which is 137.93% up from last year.
  • Per ADC Therapeutics' latest filing, its Receivables stood at $73.8 million for FY2022, which was up 137.93% from $31.0 million recorded in FY2021.
  • ADC Therapeutics' 5-year Receivables high stood at $73.8 million for FY2022, and its period low was $31.0 million during FY2021.
  • In the last 2 years, ADC Therapeutics' Receivables had a median value of $52.4 million in 2021 and averaged $52.4 million.
  • Data for ADC Therapeutics' Receivables shows a peak YoY skyrocketed of 137.93% (in 2022) over the last 5 years.
  • ADC Therapeutics' Receivables (Yearly) stood at $31.0 million in 2021, then skyrocketed by 137.93% to $73.8 million in 2022.